Search Results - "Bolkenbaas, Marieke"
-
1
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
Published in The New England journal of medicine (19-03-2015)“…In this double-blind, placebo-controlled trial involving more than 84,000 Dutch adults, the 13-valent pneumococcal conjugate vaccine was found to prevent…”
Get full text
Journal Article -
2
The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly
Published in Clinical infectious diseases (15-12-2015)“…In a post hoc analysis of the Community-Acquired Pneumonia (CAP) immunization Trial in Adults the model-predicted 13-valent pneumococcal conjugate vaccine…”
Get full text
Journal Article -
3
Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly
Published in Vaccine (03-08-2017)“…Highlights • Vaccine efficacy (VE) of PCV13 in elderly has been proven before. • VE in elderly with comorbidities was evaluated in this study. • VE of PCV13…”
Get full text
Journal Article -
4
Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study
Published in Clinical microbiology and infection (01-07-2021)“…The efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in adults to prevent community-acquired pneumonia (CAP) and lower respiratory tract infections…”
Get full text
Journal Article -
5
-
6
Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L
Published in Health and quality of life outcomes (06-01-2017)“…We aimed to evaluate health status and associated factors in community-dwelling elderly in the Netherlands. Participants from a placebo-controlled double-blind…”
Get full text
Journal Article -
7
Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly
Published in Vaccine (14-06-2016)“…Highlights • Herd effects of PCV's have not been well established for non-IPD pneumococcal CAP. • Cost-effectiveness analyses have been shown sensitive for…”
Get full text
Journal Article -
8
Vaccine against Pneumococcal Pneumonia in Adults
Published in The New England journal of medicine (02-07-2015)“…To the Editor: In their article on the efficacy of a 13-valent pneumococcal vaccine (PCV13) in the Community-Acquired Pneumonia Immunization Trial in Adults…”
Get full text
Journal Article -
9
595Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
Published in Open forum infectious diseases (01-12-2014)Get full text
Journal Article -
10
LB-7A Post-Hoc Assessment of Duration of Protection in CAPiTA (Community Acquired Pneumonia Immunization Trial in Adults)
Published in Open forum infectious diseases (01-12-2014)Get full text
Journal Article -
11
-
12
-
13
A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults)
Published in Trials in vaccinology (2016)“…•Analysis of PCV13 vaccine efficacy against community-acquired pneumonia in older adults.•Significant difference in disease-free survival in PCV13 recipients…”
Get full text
Journal Article